Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.22 USD
Change Today -0.0131 / -5.55%
Volume 549.1K
NSPR On Other Exchanges
Symbol
Exchange
NYSE Amex
As of 8:04 PM 05/28/15 All times are local (Market data is delayed by at least 15 minutes).

inspiremd inc (NSPR) Snapshot

Open
$0.25
Previous Close
$0.24
Day High
$0.25
Day Low
$0.22
52 Week High
06/20/14 - $3.25
52 Week Low
05/15/15 - $0.19
Market Cap
17.4M
Average Volume 10 Days
1.3M
EPS TTM
$-0.64
Shares Outstanding
78.0M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for INSPIREMD INC (NSPR)

Related News

No related news articles were found.

inspiremd inc (NSPR) Related Businessweek News

No Related Businessweek News Found

inspiremd inc (NSPR) Details

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex coronary and vascular diseases. It offers MGuard and MGuard prime embolic protection stents for use in patients with acute coronary syndromes, notably acute myocardial infarction, and saphenous vein graft coronary interventions; and CGuard carotid embolic prevention systems for use in carotid artery applications. The company is also developing PVGuard for use in peripheral vascular applications. It operates in the Middle East, Germany, Belarus, Spain, the Russian Federation, and internationally. The company is headquartered in Boston, Massachusetts.

55 Employees
Last Reported Date: 03/12/15

inspiremd inc (NSPR) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $519.1K
Chief Financial Officer, Chief Administrative...
Total Annual Compensation: $236.9K
Chief Operating Officer, Executive Vice Presi...
Total Annual Compensation: $194.7K
Chief Technology Officer, Chief Technical Off...
Total Annual Compensation: $201.7K
Compensation as of Fiscal Year 2014.

inspiremd inc (NSPR) Key Developments

InspireMD, Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

InspireMD, Inc. announced unaudited consolidated earnings results for the first quarter ended March 31, 2015. Revenue for the quarter ended March 31, 2015 decreased $1.0 million to $0.5 million compared to $1.5 million during the same period in 2014. The 2015 period included an expected decline in sales volume associated with the trend of doctors increasingly using drug eluting stents rather than bare metal stents in STEMI patients and the impact of the transition to a new commercial strategy built on using third party distributors for products. The loss from operations for the quarter ended March 31, 2015 was $4.9 million, a decrease of 11.7% compared to a loss of $5.5 million for the same period in 2014. The net loss for the quarter ended March 31, 2015 totaled $5.2 million, or $0.10 per basic and diluted share, compared to a net loss of $6.0 million, or $0.18 per basic and diluted share, in the same period in 2014. Non-GAAP net loss for the quarter ended March 31, 2015 was $3.8 million, or $0.08 per basic and diluted share, a decrease of 22.4% compared to a non-GAAP net loss of $4.9 million, or $0.15 per basic and diluted share, for the same period in 2014. Loss before tax expenses was $5,196,000 against $5,948,000 a year ago.

InspireMD, Inc. to Report Q1, 2015 Results on May 11, 2015

InspireMD, Inc. announced that they will report Q1, 2015 results at 9:00 AM, US Eastern Standard Time on May 11, 2015

InspireMD, Inc., Q1 2015 Earnings Call, May 11, 2015

InspireMD, Inc., Q1 2015 Earnings Call, May 11, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NSPR:US $0.22 USD -0.0131

NSPR Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $49.26 USD +0.25
Boston Scientific Corp $18.27 USD +0.28
Johnson & Johnson $101.15 USD +0.02
Medtronic PLC $77.21 USD -0.11
Sorin SpA €2.67 EUR +0.012
View Industry Companies
 

Industry Analysis

NSPR

Industry Average

Valuation NSPR Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 6.5x
Price/Book 3.3x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INSPIREMD INC, please visit www.inspire-md.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.